Redefining digital ROI: Engagement, experience, and the new metrics of success
December 18, 2025 | Engagement, RoI, experience
Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and omnichannel initiatives.
As pressure grows on pharma teams to prove the value of their digital initiatives, traditional KPIs are falling short. Engagement rates and click-throughs only tell part of the story. What matters now is meaningful impact – for your audience, and your business.
In this webinar, we explored how pharma teams can evolve their digital measurement frameworks to capture what really counts. We discussed why traditional KPIs fall short in today’s pharma landscape, how to link engagement and experience to real-world outcomes, what ROI really means for digital and omnichannel investment and how to build actionable, insight-led measurement frameworks.
Latief Ziada, from Graphite, was joined by two expert panellists — Alyssa Fenoglio, Global Head of Digital Commercial, Teva Pharmaceuticals, and Florent Edouard, Global Head of the Digital Accelerator, Sanofi.
If you’re involved in digital decision-making within pharma, check it out.
Disclaimer: The opinions shared by our panellists are solely their own and should not be taken as representative of their organisations.
This content was provided by Graphite Digital
Company Details
Latest Content from Graphite Digital
What do HCPs want from pharma medical information sites in 2026?
At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine those conversations with wider sector…
Bridging the value gap: The systems, teams and mindsets that matter
In pharma, the challenge is no longer understanding what HCPs want from digital. It’s delivering it consistently. In this webinar, we explored what needs to change inside organisations to make…
Webinar: What do HCPs really want from pharma digital in 2026?
Our research shows that healthcare professionals are not disengaging from pharma digital. They are becoming more selective about the experiences that earn their attention. To explore what this means for…
The strategic role of AI in scaling Design Systems across channels
How can pharma teams scale AI safely across channels? In this session, Ed Hart and Nicolas Barcza explore why strong Design Systems are the foundation for making AI operational, compliant…
What HCPs want from digital pharma in 2026: The value gap
We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the value gap is widening.
First impressions matter: Why getting your onboarding right is key for digital engagement
As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,…
Pharma’s digital dilemma: Finding the balance between speed, scale, and experience
What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick…
Redefining digital ROI: Engagement, experience, and the new metrics of success
Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and…
5 key digital CX challenges in pharma, and how to start solving them
Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are…
The digital reality check: How pharma measures up in 2025
Download your copy of our latest pharma white paper, exploring the latest digital trends, challenges and opportunities in pharma.